share_log

Clearside Biomedical Q3 EPS $(0.10) Beats $(0.13) Estimate, Sales $1.04M Beat $122.86K Estimate

Benzinga ·  Nov 13 05:05

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.04 million which beat the analyst consensus estimate of $122.86 thousand by 744.88 percent. This is a 20.84 percent increase over sales of $859.00 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment